SCHEMBL736832

SCHEMBL736832

NC1(C(=O)N[C@H](Cc2csc3ccccc23)C(=O)N[C@H](Cc2ccc3ccccc3c2)NC=O)CCNCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.60
OPRM1 P35372 3/20 0.39
KLKB1 P03952 3/20 0.36
KLK1 P06870 2/20 0.36
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
CTSL P07711 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
OPRD1 P41143 2/20 0.34
OPRK1 P41145 2/20 0.34
F10 P00742 2/20 0.34
TACR1 P25103 1/20 0.34
MC1R Q01726 3/20 0.34
MC4R P32245 1/20 0.34
MC3R P41968 1/20 0.34
MC5R P33032 2/20 0.33
PIN1 Q13526 1/20 0.33
CALCRL Q16602 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL737835 0.97 GHSR (0.60) GHSROPRM1KLKB1KLK1MMP2
SCHEMBL14615567 0.93 GHSR (0.52) GHSROPRM1KLKB1KLK1MMP2
SCHEMBL739675 0.91 GHSR (0.71) GHSROPRM1KLKB1KLK1MMP2
SCHEMBL737925 0.90 GHSR (0.60) GHSROPRM1KLKB1KLK1MMP2
SCHEMBL739067 0.89 GHSR (0.64) GHSROPRM1KLKB1KLK1MMP2
SCHEMBL737831 0.89 GHSR (0.64) GHSROPRM1KLKB1KLK1MMP2
SCHEMBL14615484 0.88 GHSR (0.51) GHSRKLKB1KLK1MMP2MMP9
SCHEMBL738034 0.87 GHSR (0.60) GHSRKLKB1KLK1MMP2MMP9
SCHEMBL736833 0.86 GHSR (0.59) GHSROPRM1KLKB1KLK1MMP2
SCHEMBL739292 0.85 GHSR (0.85) GHSROPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138218-B2 Growth hormone secretagogues IPSEN PHARMA S.A.S. (FR) 2012-03-20 US disclosed
US-8138218-B2 Growth hormone secretagogues IPSEN PHARMA S.A.S. (FR) 2012-03-20 US disclosed
US-20090131478-A1 Growth Hormone Secretagogues IPSEN PHARMA S.A.S. (FR) 2009-05-21 US disclosed
US-20090131478-A1 Growth Hormone Secretagogues IPSEN PHARMA S.A.S. (FR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131478-A1 Growth Hormone Secretagogues GHSR, GHRHR, GHITM GHSR 1/4885OPRM1 3398/4885KLKB1 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.